Research Partnerships Cure AHC collaborates with physicians and organizations worldwide to fund research for Alternating Hemiplegia of Childhood. They actively bring together donors, researchers and families to accelerate progress. For business development, there are opportunities to offer donor management tools, research grant platforms, and multi-organization collaboration solutions that streamline fundraising and coalition-building.

Fundraising Growth With a modest annual revenue and a very small staff, Cure AHC has room to scale its fundraising operations. They could benefit from digital fundraising platforms, event management, recurring giving programs, and donor segmentation to maximize impact. Partnerships with nonprofit software providers and analytics services could help optimize efficiency and outcomes.

Tech Modernization The organization relies on Squarespace and standard web analytics to engage supporters, suggesting a strong online presence but room for modernization. There is potential to propose website optimization, marketing automation, CRM integration, and enhanced data analytics to improve donor conversion and engagement. Accessibility improvements and content optimization could broaden reach with patient families and clinicians.

Founder Driven Founders Jeff and Renee Wuchich lead Cure AHC with a deeply personal, patient-centered mission. This founder-driven focus often resonates with patient advocacy groups and philanthropic funders. Opportunities exist to partner on advocacy campaigns, patient registries, and co-branded fundraising initiatives with corporate sponsors.

Gene Therapy Focus Cure AHC has pursued cutting-edge gene therapy research, specifically Adeno Associated Virus therapies, since earlier years. This active research stance opens doors for collaborations with biotech companies, CROs, and academic partners, as well as grant-funded research programs. Potential sales angles include research funding consultancies, lab services, and grant-writing support for clinical research initiatives.